--- title: "Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket" type: "News" locale: "en" url: "https://longbridge.com/en/news/286749702.md" description: "LiveRamp Holdings Inc (NYSE: RAMP) shares surged over 26% in pre-market trading following its acquisition by Publicis for $2.2 billion. The deal values LiveRamp at $38.50 per share. The company also reported better-than-expected Q4 earnings, with earnings of 52 cents per share and sales of $206.092 million. Other notable pre-market movers included Sunshine Biopharma Inc (SBFM) up 182.4% and Bitcoin Depot Inc (BTM) down 73.7% due to bankruptcy filing." datetime: "2026-05-18T09:38:29.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286749702.md) - [en](https://longbridge.com/en/news/286749702.md) - [zh-HK](https://longbridge.com/zh-HK/news/286749702.md) --- # Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket Shares of **Liveramp Holdings Inc** (NYSE:RAMP) rose sharply in pre-market trading. Publicis acquired LiveRamp for $2.2 billion in all-cash deal at $38.50 per share. LiveRamp also reported better-than-expected fourth-quarter earnings. LiveRamp reported quarterly earnings of 52 cents per share which beat the analyst consensus estimate of 50 cents per share. The company reported quarterly sales of $206.092 million which beat the analyst consensus estimate of $205.513 million. Liveramp shares jumped 26.5% to $37.51 in pre-market trading. Here are some other stocks moving in pre-market trading. ### Gainers - **Sunshine Biopharma Inc** (NASDAQ:SBFM) gained 182.4% to $0.80 in pre-market trading after dipping 39% on Friday. - **NextNRG Inc** (NASDAQ:NXXT) gained 96.5% to $0.55 in pre-market trading. NextNRG will host a conference call on Monday, May 18, to discuss its first quarter financial results. - **Geovax Labs Inc** (NASDAQ:GOVX) gained 65.6% to $2.04 in pre-market trading. - **Smart Powerr Corp**. (NASDAQ:CREG) rose 52.4% to $0.73 in pre-market trading. Smart Powerr posted a first-quarter loss of 3 cents per share.   - **Picard Medical In**c (NYSE:PMI) gained 52.4% to $0.24 in pre-market trading after the company reported a first-quarter loss of 10 cents per share. - **DirectBooking Technology Co Ltd** (NASDAQ:ZDAI) rose 33.7% to $1.94 in pre-market trading after falling 14% on Friday. - **GCT Semiconductor Holding Inc** (NYSE:GCTS) rose 27.2% to $2.32 in pre-market trading after gaining 27% on Friday. - **Compass Pathways PLC** (NYSE:CMPS) jumped 15.8% to $12.00 in pre-market trading. - **Destiny Tech100 Inc** (NYSE:DXYZ) gained 12.7% to $53.68 in pre-market trading after adding around 5% on Friday. ### Losers - **Bitcoin Depot Inc** (NASDAQ:BTM) declined 73.7% to $0.77 in pre-market trading as the company filed Chapter 11 bankruptcy. - **Edible Garden AG Inc** (NASDAQ:EDBL) tumbled 27% to $0.28 in pre-market trading. Edible Garden reported first-quarter results on Friday. - **P3 Health Partners Inc** (NASDAQ:PIII) fell 26.4% to $8.29 in pre-market trading. P3 Health Partners shares jumped 180% on Friday after the company reported better-than-expected first-quarter EPS results. - **Artelo Biosciences In**c (NASDAQ:ARTL) fell 23.4% to $1.41 in pre-market trading. Artelo Biosciences said it will terminate offering agreement effective May 18. - **Hcw Biologics Inc** (NASDAQ:HCWB) fell 22.3% to $0.94 in pre-market trading. HCW Biologics shares jumped 262% on Friday after the company reported better-than-expected first-quarter financial results. - **Amaze Holdings In**c (NYSE:AMZE) dipped 21.5% to $0.13 in pre-market trading. Amaze Holdings posted a first-quarter loss of 16 cents per share. - **Dreamland Lt**d (NASDAQ:TDIC) fell 20.2% to $0.82 in pre-market trading after gaining 30% on Friday. - **Haoxi Health Technology Ltd** (NASDAQ:HAO) shares dipped 11.2% to $4.74 in pre-market trading after falling 14% on Friday. - **Regeneron Pharmaceuticals Inc** (NASDAQ:REGN) dipped 10.5% to $625.00 in pre-market trading. Regeneron's Fianlimab combination failed to reach statistical significance in first-line unresectable or metastatic melanoma Phase 3 trial. - **Li Auto Inc** (NASDAQ:LI) fell 9.5% to $16.74 in pre-market trading after declining 4% on Friday. _Photo via Shutterstock_ ### Related Stocks - [BTM.US](https://longbridge.com/en/quote/BTM.US.md) - [RAMP.US](https://longbridge.com/en/quote/RAMP.US.md) - [SBFM.US](https://longbridge.com/en/quote/SBFM.US.md) - [SBFMW.US](https://longbridge.com/en/quote/SBFMW.US.md) - [BTCHKD.VAHK](https://longbridge.com/en/quote/BTCHKD.VAHK.md) - [BTCUSD.VAHK](https://longbridge.com/en/quote/BTCUSD.VAHK.md) - [NXXT.US](https://longbridge.com/en/quote/NXXT.US.md) - [GOVX.US](https://longbridge.com/en/quote/GOVX.US.md) - [CREG.US](https://longbridge.com/en/quote/CREG.US.md) - [PMI.US](https://longbridge.com/en/quote/PMI.US.md) - [ZDAI.US](https://longbridge.com/en/quote/ZDAI.US.md) - [GCTS.US](https://longbridge.com/en/quote/GCTS.US.md) - [CMPS.US](https://longbridge.com/en/quote/CMPS.US.md) - [DXYZ.US](https://longbridge.com/en/quote/DXYZ.US.md) - [EDBL.US](https://longbridge.com/en/quote/EDBL.US.md) - [PIII.US](https://longbridge.com/en/quote/PIII.US.md) - [ARTL.US](https://longbridge.com/en/quote/ARTL.US.md) - [HCWB.US](https://longbridge.com/en/quote/HCWB.US.md) - [AMZE.US](https://longbridge.com/en/quote/AMZE.US.md) - [TDIC.US](https://longbridge.com/en/quote/TDIC.US.md) - [HAO.US](https://longbridge.com/en/quote/HAO.US.md) - [REGN.US](https://longbridge.com/en/quote/REGN.US.md) - [LI.US](https://longbridge.com/en/quote/LI.US.md) - [02015.HK](https://longbridge.com/en/quote/02015.HK.md) - [GOVXW.US](https://longbridge.com/en/quote/GOVXW.US.md) - [GCTS+.US](https://longbridge.com/en/quote/GCTS+.US.md) - [BTMWW.US](https://longbridge.com/en/quote/BTMWW.US.md) - [EDBLW.US](https://longbridge.com/en/quote/EDBLW.US.md) - [PIIIW.US](https://longbridge.com/en/quote/PIIIW.US.md) ## Related News & Research - [Key facts: Publicis to Buy LiveRamp at $38.50; LiveRamp Reports Growth](https://longbridge.com/en/news/286729179.md) - [France's Publicis to buy US data firm LiveRamp in $2.2 billion](https://longbridge.com/en/news/286678167.md) - [Publicis Groupe expands AI ambitions with $2.2B LiveRamp buyout](https://longbridge.com/en/news/286689759.md) - [Publicis Makes AI Data Play With LiveRamp Acquisition](https://longbridge.com/en/news/286768409.md) - [BRIEF-Publicis To Acquire LiveRamp To Accelerate Data Co-Creation For Smarter Agents](https://longbridge.com/en/news/286677787.md)